Medicare Enrolled
Dr. Matvey Brokhin, MD
Endocrinology · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Brokhin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brokhin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Brokhin
Dr. Matvey Brokhin is an endocrinology specialist in Brooklyn, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Brokhin performed 4,955 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Brokhin received a total of $281,889 from 64 pharmaceutical and/or device companies across 1943 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Brokhin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 14% volume in NY
$281,889 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,955
Medicare services
Top 14% in NY for endocrinology
Not available
Unique patients (not deduplicated)
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,222 | $69 | $127 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,174 | $111 | $191 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
936 | $8 | $13 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
922 | $50 | $86 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
253 | $3 | $20 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
211 | $113 | $204 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
155 | $30 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $146 | $252 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
25 | $103 | $189 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $80 | $126 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$281,889
Total received (2018-2024)
Avg $40,270/year across 7 years
Top 3% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
1,943
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$24,987
2023
$24,815
2022
$11,145
2021
$22,065
2020
$35,870
2019
$74,369
2018
$88,638
Payments by company (2024)
Amgen Inc.
$19,543
Novo Nordisk Inc
$796
Amneal Pharmaceuticals LLC
$603
Boehringer Ingelheim Pharmaceuticals, Inc.
$491
Esperion Therapeutics, Inc.
$486
Chiesi USA, Inc.
$446
Lilly USA, LLC
$437
Xeris Pharmaceuticals, Inc.
$388
ABBVIE INC.
$303
Corcept Therapeutics
$283
Novartis Pharmaceuticals Corporation
$266
Astellas Pharma US Inc
$142
Mannkind Corporation
$140
SANOFI-AVENTIS U.S. LLC
$119
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$109
Almatica Pharma LLC
$104
Kyowa Kirin, Inc.
$86
AIMMUNE THERAPEUTICS, INC.
$71
CeQur Corporation
$44
Ascendis Pharma Inc
$42
AstraZeneca Pharmaceuticals LP
$25
Alvogen Inc
$24
BETA BIONICS, INC.
$21
Amphastar Pharmaceuticals, Inc.
$20
Top 3 companies account for 83.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$99,798
SANOFI-AVENTIS U.S. LLC
$63,061
AstraZeneca Pharmaceuticals LP
$60,846
Horizon Therapeutics plc
$11,969
Shire North American Group Inc
$11,659
Regeneron Healthcare Solutions, Inc.
$11,407
Novo Nordisk Inc
$3,007
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,040
Amneal Pharmaceuticals LLC
$1,993
Amarin Pharma Inc.
$1,532
Novartis Pharmaceuticals Corporation
$956
Xeris Pharmaceuticals, Inc.
$903
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$893
Mannkind Corporation
$866
AbbVie Inc.
$809
Lilly USA, LLC
$722
Merck Sharp & Dohme Corporation
$713
Ipsen Biopharmaceuticals, Inc
$712
Radius Health, Inc.
$661
Esperion Therapeutics, Inc.
$606
MannKind Corporation
$561
IBSA Pharma Inc.
$453
Chiesi USA, Inc.
$446
Corcept Therapeutics
$432
Ferring Pharmaceuticals Inc.
$425
Amryt Pharma Holdings Ltd
$419
ABBVIE INC.
$376
VistaPharm, Inc.
$323
ARBOR PHARMACEUTICALS, INC.
$281
Insulet Corporation
$251
Dexcom, Inc.
$246
AbbVie, Inc.
$232
Arbor Pharmaceuticals, Inc.
$216
TOLMAR Pharmaceuticals, Inc.
$165
Kyowa Kirin, Inc.
$159
Astellas Pharma US Inc
$142
Bayer HealthCare Pharmaceuticals Inc.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$125
Janssen Pharmaceuticals, Inc
$122
DEXCOM, INC.
$115
Almatica Pharma LLC
$104
Abbott Laboratories
$94
Ascendis Pharma Inc
$91
Gemini Laboratories, LLC
$71
AIMMUNE THERAPEUTICS, INC.
$71
Zealand Pharma US, Inc.
$67
Amphastar Pharmaceuticals, Inc.
$64
Merck Sharp & Dohme LLC
$62
Intra-Sana Laboratories
$53
Endo Pharmaceuticals Inc.
$53
Ultragenyx Pharmaceutical Inc.
$49
CeQur Corporation
$48
Azurity Pharmaceuticals, Inc.
$45
Alvogen Inc
$42
Travere Therapeutics, Inc.
$29
RECORDATI_RARE_DISEASES_INC.
$25
BioMarin Pharmaceutical Inc.
$24
Rhythm Pharmaceuticals, Inc.
$22
BETA BIONICS, INC.
$21
Nestle HealthCare Nutrition Inc.
$20
Synergy Pharmaceuticals Inc
$19
Genentech USA, Inc.
$19
PFIZER INC.
$17
Becton, Dickinson and Company
$15
Top 3 companies account for 79.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano · BELSOMRA · CREON · CRYSVITA · CRYSViTA · CeQur Simplicity · Cholbam · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVKEEZA · Edarbi · FARXIGA · FENSOLVI · FORTEO · FREESTYLE LIBRE 2 · FreeStyle Libre · GVOKE HYPOPEN · GVOKE PFS · Gliadel · INCRELEX · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LANTUS · LEQVIO · LICART · LINZESS · LOKELMA · LUPRON DEPOT · Licart · MYALEPT · MYCAPSSA · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · Norditropin · Omnipod · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · RECORLEV · RELTONE 200 MG · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STEGLUJAN · SYNTHROID · Saxenda · Skytrofa · Sogroya · Somatuline Depot · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULANCE · Thyquidity · Tirosint · Tresiba · Triptodur · Trulance · Tymlos · UBRELVY · UNITHROID · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Veozah · Victoza · Wegovy · Xofluza · ZEGALOGUE · ZENPEP · ZEPBOUND · ZOMACTON · iLet Bionic Pancreas
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
619
County median income
$78,548
Nearest hospital to ZIP centroid (approximate)
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Brokhin is a clinical cardiology specialist, with above-average Medicare volume (top 14% in NY), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Brokhin experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Brokhin performed 1,222 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Brokhin receive payments from pharmaceutical companies?
Yes. Dr. Brokhin received a total of $281,889 from 64 companies across 1,943 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brokhin's costs compare to other endocrinologists in Brooklyn?
Dr. Brokhin's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brokhin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Brooklyn
Browse endocrinologists in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NY
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NY
Which NY endocrinologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology